Apolipoprotein A-I(R151C)(Paris) is defective in activation of lecithin : cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux
U. Daum et al., Apolipoprotein A-I(R151C)(Paris) is defective in activation of lecithin : cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux, J MOL MED-J, 77(8), 1999, pp. 614-622
Citations number
45
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
ApoA-I(R151)(Paris) is a natural apolipoprotein (apo) A-I variant that is a
ssociated with low levels of high-density lipoprotein cholesterol (HDL-chol
esterol) and the partial deficiency of lecithin:cholesterol acyltransferase
(LCAT) in the plasma of heterozygous carriers. We compared the abilities o
f recombinant normal apoA-I and recombinant apoA-I(R151C)(Paris) to clear a
n emulsion of dimyristoylphosphatidylcholine (DMPC), to form reconstituted
lipoproteins with dipalmitoylphosphatidylcholine (DPPC), to activate LCAT,
and to promote efflux of biosynthetic cholesterol from porcine aortic smoot
h muscle cells (SMCs) or of exogenous cholesterol from lipid-loaded mouse p
eritoneal macrophages. Recombinant apoA-I(R151C)(Paris) occurred in monomer
ic and dimeric forms at a ratio of 60:40. Normal apoA-I and apoA-I(R151C)(P
aris) cleared DMPC emulsions at equal rates. Both isoforms associated compl
etely with DPPC during cholate dialysis. Normal apoA-I formed one single pa
rticle with a mean diameter of 9.3 nm, whereas apoA-I(R151)(Paris) gave ris
e to three particles with mean diameters of 9.3 nm (containing 74% of apoA-
I), 10.6 nm, and 12.1 nm, respectively. Compared to normal apoA-I, apoA-I(R
151C)(Paris) had a reduced LCAT-cofactor activity with a 60% lower V-max/K-
m ratio due to a 50% higher affinity constant, K-m. During incubations for
10 min and 360 min, normal apoA-I/DPPC complexes and apoA-I(R151 C)(Paris)/
DPPC complexes were equally efficient in releasing biosynthetic cholesterol
from SMCs. In the lipid-free form, apoA-I(R151C)(Paris) induced normal hyd
rolysis of cholesteryl esters and normal cholesterol efflux from lipid-load
ed mouse-peritoneal macrophages. In conclusion, in addition to its ability
to form homo- and heterodimers, apoA-I(R151C)(Paris) is characterized by de
fective LCAT-cofactor activity but by normal lipid binding and cholesterol-
efflux-promoting abilities.